S
TLSI icon

SignatureFD’s TriSalus Life Sciences TLSI Stock Holding History

SignatureFD’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455 Hold
100
– – ﹤0.01% 3375
2026
Q1 		$400 Hold
100
– – ﹤0.01% 3337
2025
Q4 		$698 Hold
100
– – ﹤0.01% 3173
2025
Q3 		$465 Hold
100
– – ﹤0.01% 3200
2025
Q2 		$545 Hold
100
– – ﹤0.01% 3091
2025
Q1 		$552 Hold
100
– – ﹤0.01% 3155
2024
Q4 		$501 Hold
100
– – ﹤0.01% 3141
2024
Q3 		$461 Hold
100
– – ﹤0.01% 3110
2024
Q2 		$552 Hold
100
– – ﹤0.01% 2979
2024
Q1 		$975 Buy
+100
New +$923 ﹤0.01% 2955

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

SignatureFD's TLSI Position: Q2 2026 in Review

SignatureFD held its TriSalus Life Sciences (TLSI) position steady in Q2 2026 at 100 shares worth $455. The position accounts for ﹤0.01% of the portfolio, ranked #3375.

SignatureFD first reported a position in TLSI in Q1 2024 and has held it in 10 quarters since. The position peaked at $975 in Q1 2024. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • SignatureFD held 100 shares of TriSalus Life Sciences worth $455 as of Q2 2026.
  • SignatureFD left its TriSalus Life Sciences share count unchanged in Q2 2026.
  • TriSalus Life Sciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3375 holding.
  • SignatureFD first reported a position in TriSalus Life Sciences in Q1 2024 and has held it in 10 quarters since.
  • SignatureFD's TriSalus Life Sciences position peaked at $975 in Q1 2024.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.